-
Amgen Full Year 2025 Financial Report
Amgen
Amgen's 2025 revenue rose 10%, reaching $36.75B, driven by strong product sales and innovation. The company projects continued growth in 2026, with a focus on R&D, cost control, and shareholder returns.
-
-
-
-
-
-
Top 10 Immunology Drugs to Watch in 2024
AbbVie
Explore the top 10 best-selling immunology drugs of 2023, including Humira, Dupixent, Stelara, and more. Discover how these innovative therapies are shaping the market, driving clinical breakthroughs, and overcoming competitive challenges.
-
佛坪县|
马公市|
哈密市|
博白县|
宝山区|
宝坻区|
霍林郭勒市|
峨眉山市|
望城县|
多伦县|
潼南县|
宁武县|
河源市|
张家川|
汉川市|
密云县|
甘谷县|
肇源县|
淅川县|
尉犁县|
五大连池市|
迭部县|
方正县|
常德市|
普定县|
九龙城区|
张家港市|
永川市|
大姚县|
麻阳|
赣榆县|
荥阳市|
娄底市|
信宜市|
攀枝花市|
丁青县|
澄城县|
东乡|
天峻县|
静海县|
库尔勒市|